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Oas1a
Oas1bThe murine 2′–5′ oligoadenylate synthetase 1a (Oas1a) and Oas1b genes are type 1 IFN responsive genes.
Oas1a is an active synthetase with broad antiviral activity mediated through RNase L. Oas1b is inactive but
can inhibit Oas1a synthetase activity and mediate a ﬂavivirus-speciﬁc antiviral activity through an unknown
RNase L-independent mechanism. Analysis of promoter elements regulating gene transcription conﬁrmed
that an IFN-stimulated response element (ISRE) is required for IFN beta-activation but neither the overlap-
ping IRF binding site present in both promoters nor the adjacent Oas1b NF-kappa B site is required. Mutation
of the overlapping STAT site negatively affected IFN beta-induction of Oas1a but not of Oas1b. Also, IFN beta
induction of Oas1a was STAT1- and STAT2-dependent, while induction of Oas1b was STAT1-independent but
STAT2-dependent. The two promoters differ at a single nucleotide in the STAT site. The data indicate that
these two duplicated genes can be differentially regulated by IFN beta.
© 2011 Elsevier Inc. All rights reserved.Introduction
The recognition of viral dsRNA by cellular sensors in infected cells
leads to activation of the NF-kappa B, IRF-3 and ATF2/c-Jun transcrip-
tion factors that bind cooperatively to the interferon (IFN) beta pro-
moter and activate its transcription (Merika and Thanos, 2001). IFN
beta secreted by infected cells binds to IFN alpha/beta receptors on
the surfaces of both infected and uninfected cells resulting in activa-
tion of JAK1 and Tyk2 kinases that phosphorylate STAT1 and STAT2
transcription factors. Phosphorylated STAT1 and STAT2 and IFN regu-
latory factor 9 (IRF-9) form the IFN stimulated gene factor 3 complex
(ISGF3) that translocates to the nucleus where it binds to IFN stimu-
lated response elements (ISREs) in the promoters of IFN stimulated
genes (ISGs) and upregulates their expression (Stark et al., 1998).
Three oligoadenylate synthetase genes (OAS1, OAS2 and OAS3)
and one OAS-like (OASL) gene have been identiﬁed in the human ge-
nome (Hovnanian et al., 1998; Rebouillat et al., 1998). The transcripts
of three of these genes are alternatively spliced and polymorphisms
have been identiﬁed that alter splicing sites. Five isoforms have been
reported for OAS1 (p42, p44, p46/p48 and p52), two for OAS2 (p69
and p71), one for OAS3 (p100) and two for OASL (p30 and p59)
(Bonnevie-Nielsen et al., 2005; Hartmann et al., 1998; Hovnanian et
al., 1999; Justesen et al., 2000; Rebouillat et al., 1998). In contrast,
the mouse genome contains eight OAS1 (Oas1a-Oas1h), two OASLorgia State University, P.O. Box
301.
rights reserved.(Oasl1 and Oasl2), one OAS2 (Oas2) and one OAS3 (Oas3) gene ortho-
logs (Justesen et al., 2000; Kakuta et al., 2002; Rutherford et al., 1991;
Shibata et al., 2001). Gene duplication, rather than alternative splicing,
is responsible for the multiple murine Oas1 isoforms (Perelygin et al.,
2006). Enzymatically active OAS proteins play an important antiviral role.
When activated by viral dsRNA, they catalyze the synthesis of short 2′–5′-
oligoadenylates (2–5A) from ATP. 2–5A activates latent endonuclease
RNase L which degrades both cellular and viral single-stranded RNAs
(Samuel, 2001). Among the eight murine Oas1 proteins, only Oas1a and
Oas1g have been reported to be active 2′–5′-oligoadenylate synthetases
(Elbahesh et al., 2011; Kakuta et al., 2002). However, the inactive synthe-
tase Oas1b mediates resistance to ﬂavivirus-induced disease through an
unknown mechanism that is independent of RNase L (Scherbik et al.,
2006). The ﬂavivirus-induced disease resistant mouse strain C3H/RV is
homozygous for the dominant Oas1br allele encoding a full length
Oas1b protein,while the congenic susceptiblemouse strain C3H/He is ho-
mozygous for the recessive Oas1bs allele that encodes a C-terminally
truncated Oas1btr protein (Perelygin et al., 2002). A previous study
showed that the full length Oas1b protein, which is an inactive synthe-
tase, can inhibit in vitro Oas1a synthetase activity in a dose-dependent
manner and reduce 2–5A production in vivo in response to poly(I:C)
(Elbahesh et al., 2011). A similar functionwas reported forOas1d, another
of the inactive Oas1 proteins (Yan et al., 2005).
Each of the human OAS genes contains an ISRE in its promoter and
is induced by type I IFN (Floyd-Smith et al., 1999; Hartmann et al.,
1998; Rebouillat et al., 2000; Wang and Floyd-Smith, 1997; Yu et al.,
1999). Similarly, murine Oas gene expression with the exception of
Oas1f was reported to be activated by type I IFN (Eskildsen et al.,
2002, 2003). A previous TFSEARCH analysis predicted transcription
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rine Oas1a-h, Oas2 and Oas3 genes and identiﬁed an ISRE in only the
promoters of the Oas1a, Oas1b, Oas1g and Oas2 genes (Mashimo et
al., 2003). Only the ISRE in the Oas1b promoter was predicted to over-
lap GAS and NF-kappa B sites. These results suggested the possibility
of differential regulation of Oas1a and Oas1b expression by IFN and/or
viral infection but this prediction was not functionally tested.
In the present study, the Oas1a and Oas1b promoters from both
C3H/RV and C3H/He mouse embryoﬁbroblasts (MEFs) were cloned
and sequenced. A GENOMATIX search of the Oas1a andOas1b promoter
sequences predicted that neither had a TATA box but that both had a ca-
nonical initiator element (INR). An inverted CCAAT element (ICE) was
predicted and functional analysis data suggested that it is important
for the basal activities of the C3H/He and C3H/RV Oas1b promoters
and the C3H/RV Oas1a promoter. The C3H/He Oas1a promoter con-
tained a mutation in this site that was predicted to make it nonfunc-
tional. A single ISRE as well as overlapping STAT and IRF sites were
predicted in both promoters. Functional mapping of the Oas1a and
Oas1b promoters by sequential 5′ deletion and TFBS mutagenesisFig. 1. IFN beta-induced upregulation of Oas1a and Oas1b genes in vivo and of promoter rep
beta for 3 h or left untreated (control). Total RNA was extracted and Oas1a and Oas1b mRN
malized to the level of GAPDH mRNA in the same sample and is shown as the fold change
(RQU). Each experiment was performed in triplicate and representative data from one of t
(B) Oas1a and (C) Oas1b promoter fragments of different lengths. C3H/RV MEFs were co-
vector DNA and Renilla luciferase reporter vector DNA (transfection efﬁciency control). At
for 3 h or left untreated (control). Cell lysates were prepared and luciferase activity was mea
for each sample. Error bars represent standard error of the mean (SEM) (n=3). Signiﬁcantindicated that the ISRE aswell as the overlapping STAT site are required
for Oas1a promoter induction by IFN beta while Oas1b expression re-
quires only the ISRE. Also, both STAT1 and STAT2 are required for
Oas1a upregulation by IFN beta, while only STAT2 is required for
Oas1b upregulation. A single nucleotide (nt) difference between the
STAT sites of theOas1b andOas1a promoters appeared to be responsible
for the differential STAT1-dependence of Oas1a and Oas1b expression.
Results
Mapping the Oas1a and Oas1b gene promoter regions required for basal
promoter expression and induction by IFN beta
The Oas1a and Oas1b genes are ISGs and after treatment of C3H/He
MEFs with 1000 U/ml of murine IFN beta for 3 h, Oas1a mRNA was
upregulated by about 9 fold while Oas1b mRNA was upregulated by
about 7 fold (Fig. 1A). The time and dose of IFN treatment was selected
based on a previous study showing that the highest level of ISG induc-
tion was at 3 h after IFN treatment of MEFs and that the levels of ISGorter constructs in vitro. (A) C3H/He MEFs were treated with 1000 U/ml of murine IFN
A levels were measured by real time qRT-PCR. The mRNA level for each gene was nor-
over the amount of mRNA in mock samples expressed in relative quantiﬁcation units
hree independent experiments are shown. Luciferase reporter assays were done with
transfected with either a Fireﬂy luciferase reporter construct DNA or a control empty
24 h after transfection, MEFs were either treated with 1000 U/ml of murine IFN beta
sured in triplicate. Fireﬂy luciferase activity was normalized to Renilla luciferase activity
differences were determined with a Student's t test (*, Pb0.05).
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beta (Scherbik et al., 2007). The regions of the Oas1a and Oas1b proxi-
mal promoters required for basal gene expression and activation by
IFN betawere thenmapped using luciferase reporter assays. Two ﬁreﬂy
luciferase reporter gene constructs, one containing a C3H/RV Oas1a
gene promoter fragment [Oas1a (−1768,+28)] and the other contain-
ing a C3H/RV Oas1b gene promoter fragment [Oas1b (−1398, +51)],
were ﬁrst generated and then a set of 5′ sequentially deleted constructs
wasmade for each promoter. C3H/RVMEFs were transfected with con-
struct DNA, and 24 h later cell lysates were harvested and used to ana-
lyze basal promoter activity. To analyze the effect of IFN on Oas1
promoter activity, cells transfected with a luciferase reporter for 24 h
were incubated with murine IFN beta. Initial pilot experiments showed
that although luciferase activity was the highest at both 3 and 6 h after
treatment, the 3 h peak levelwas themost reproducible. At 24 and 48 h,
luciferase activity was signiﬁcantly decreased. Based on these prelimi-
nary results and the maximum half-life of the ﬁreﬂy luciferase protein
of 4 h (Brandes et al., 1996; Thompson et al., 1991), assays were done
in all subsequent luciferase reporter experiments after 3 h of IFN beta
treatment. Low basal luciferase activities were detected for both the
longest Oas1a (−1768, +28) construct (Fig. 1B) and the longest
Oas1b (−1398, +51) construct (Fig. 1C). These constructs showed a
modest but signiﬁcant increase in promoter activity after IFN treatment.
The observation that the longest Oas1a and Oas1b promoter fragments
tested produced the lowest reporter activities suggested the presence of
upstream transcriptional repressor elements that negatively affected
the basal and IFN-induced expression levels of both promoters.
Promoter constructs with sequential 5′ deletions were used to de-
termine the shortest Oas1a and Oas1b promoter fragments able to pro-
duce increased luciferase activity upon stimulation with IFN beta. Each
of the 5′ deleted Oas1a promoter constructs tested produced similar
signiﬁcantly increased basal luciferase activities compared to the
Oas1a (1768, +28) construct and the activities for each of these con-
structs increased upon stimulationwith IFN beta (Fig. 1B). For instance,
the Oas1a (−87, +28) and Oas1a (−854, +28) constructs had basal
activities that were 7.1 and 8.6 fold higher, respectively, than that of
the Oas1a (−1768, +28) construct and both showed a 1.75 fold in-
crease in luciferase activity after stimulationwith IFNbeta. These results
indicated that the TFBSs required for IFN induction of the Oas1a are lo-
cated between−87 and +28.
In contrast to what was observed with the truncated Oas1a con-
structs, the activities of each of the 5′ deleted Oas1b constructs varied.
The Oas1b (−576, +51) construct showed a 21 fold increase over the
activity produced by the Oas1b (−1398, +51) construct (Fig. 1C).
Constructs that were either shorter or longer than Oas1b (−576, +
51) produced lower basal activities. The observation that the basal
activity of the Oas1b (−116 to +51) construct was 2.5 fold lower
than that of Oas1b (−576, +51) suggested that the region between
−576 and−116 contains elements that enhance basal Oas1b expres-
sion. As the length of the Oas1b constructs increased beyond
−576 bp, the basal activity decreased suggesting the presence of re-
pressor elements in this region. The activity of each of the truncated
Oas1b promoter constructs was induced to a similar extent above
its basal level by IFN beta treatment (Fig. 1C) indicating that the ele-
ments required for the induction of the Oas1b promoter by IFN beta
are located between −116 and +51 bp.
Although the results obtained were reproducible and statistically
signiﬁcant, basal levels were high and the maximal induction observed
with IFN beta was about 2 fold. The low levels of induction by IFN are
likely to be due to the use of promoter fragments with only a single
ISRE in the context of a natural promoter sequence which also contains
multiple additional TF binding sites that modulate both basal and IFN-
induced luciferase activity. Previous studies using natural TLR9 (Guo
et al., 2005) and RIG-I (Su et al., 2007) promoter sequences with single
copies of an ISRE also reported a 2 fold or lower activation of the report-
er gene after stimulation with IFN beta.Analysis of the core promoter elements in the Oas1a and Oas1b promoters
Elements in the−87 to +28 C3H/RV Oas1a promoter fragment and
in the−116 to +51 C3H/RV Oas1b promoter fragment were predicted
with GENOMATIX and TFSEARCH programs. Neither promoter contained
a TATA box but each contained an INR (Fig. 2), an element often found in
TATA-less promoters and known to be able to direct transcriptional initi-
ation (Smale, 1997; Smale and Baltimore, 1989). Within the INR consen-
sus C/TC/TA+1NA/TC/TC/T, the adenine is the transcription start site (TSS) and
this nt was used to predict the location of the Oas1a and Oas1b TSSs. The
GENOMATIX program also predicted an inverted CCAAT element (ICE) at
−63 to−68 in theOas1a promoter and at−62 to−67 in theOas1b pro-
moter. CCAAT boxes in either the forward (CCAAT) or reverse (ICE;
ATTGG) orientation are typically located about 60 to 100 nt upstream of
the TSS (Dolﬁni et al., 2009; Mantovani, 1999). To determine whether
the predicted ICE plays a functional role in the Oas1a and Oas1b pro-
moters, two nts (ATTGG→ATCCG) were substituted in this element in
the Oas1a (−854, +28) and Oas1b (−576, +51) constructs. A GENO-
MATIX search conﬁrmed that the introduced mutations eliminated the
targeted binding site and did not create a new TFBS. Mutation of ICE re-
duced the basal luciferase activity of the Oas1a and Oas1b promoters by
43% and 40%, respectively, but did not negatively affect induction of either
promoter by IFN beta (Fig. 3A). IFN beta induced the wild type and ICE-
mutated Oas1a promoters by 1.7- and 1.9 fold, respectively, and the
wild type and ICE-mutated Oas1b promoter by 1.4 and 1.5 fold,
respectively.
DNA probes consisting of the−88 to−49 bp for Oas1a or−82 to
−48 bp forOas1b (Table 3)were next used in an electrophoreticmobil-
ity shift assay (EMSA) to determine whether TFs bind to the ICE se-
quence. Oas1a and Oas1b probes with a wild type ICE bound to two
complexes in nuclear extracts from untreated C3H/RV MEFs (Fig. 3B).
With both probes, the upper band was much darker than the lower
band. These bands were either not detected or were much fainter
when a speciﬁc unlabeled competitor DNAwas included in the reaction
suggesting that the binding detected was speciﬁc. Neither of the shift
bands was observed when an Oas1a probe containing a mutated ICE
was tested. An Oas1b probe with a mutated ICE detected a faint lower
complex band but did not detect an upper complex band. The results
suggest that nuclear extracts from untreated control cells contain TFs
that bind to the ICE. Although the TFs binding to the ICE in the Oas1a
and Oas1b promoters were not identiﬁed, both the reporter assay
(Fig. 3A) and the EMSA (Fig. 3B) results suggest that the ICE element
plays a role in the regulation of basal transcription from both genes.
Comparison of the sequences of the Oas1a and Oas1b promoters in resis-
tant C3H/RV and susceptible C3H/He MEFs
To determine whether the sequences of the Oas1a or Oas1b pro-
moters differ between congenic ﬂavivirus disease susceptible C3H/He
and ﬂavivirus disease resistant C3H/RV mice, Oas1a (−1768, +28)
and Oas1b (−1398, +51) DNA fragments were ampliﬁed by PCR
from MEFs from each mouse strain, cloned and sequenced. Although
complete identity was observed between the C3H/RV and C57BL/6J
(NT_078458.6) Oas1a and Oas1b promoter sequences, the C3H/He
Oas1a promoter sequence differed by T to C substitutions at positions
−66 and −298 and the C3H/He Oas1b promoter sequence differed
by a G to C substitution at position +15 and a 4 nt deletion between
−327 and −323. GENOMATIX and TFSEARCH TFBS searches of the
C3H/He promoter sequences predicted that only the T to C substitution
at−66 in the Oas1a promoter was located in a TFBS. This substitution
changed the ICE from ATTGG to ATCGG. Based on the observation that
mutation of the ICE from ATTGG to ATCCG signiﬁcantly decreased the
basal activities of both the C3H/RVOas1a and Oas1b promoters, the sin-
gle nt substitution in the C3H/He Oas1a promoter producing a ATCGG
ICE sequence would be expected to reduce the basal expression level
of the Oas1a gene in C3H/He MEFs.
Fig. 2. Predicted TFBSs in the Oas1a and Oas1b promoters. TFBSs predicted by the GENOMATIX search program. The locations of the DNA fragments with respect to the predicted TSS
(indicated by an arrow) in an INR are indicated. Substituted nts in both promoters are underlined and substitutions made in promoter fragments are shown above arrows indicating
the boundaries of individual TFBSs.
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Both the previously published search (Mashimo et al., 2003) and the
TFSEARCH and GENOMATX TFBS searches done in this study predicted
canonical ISREs with identical sequences (5′ GGGAAATGGAAACT 3′)
between −22 to −9 bp in the Oas1a promoter and between −23 to
−10 bp in the Oas1b promoter (Fig. 2B). To determine whether the
components of the ISGF3 complex bind to the predicted Oas1a and
Oas1b ISREs,−31 to+6 bp Oas1a and−32 to+5 bp Oas1b DNA frag-
ments were used as probes in EMSAs with nuclear extracts from
untreated or murine IFN beta-treated MEFs. Two bands were detected
with the Oas1a probe and three with the Oas1b probe using nuclear ex-
tracts from IFN-treated cells (Fig. 4A). However, the upper complex
band was not observed with either probe when the reaction was done
with nuclear extracts from untreated cells. To determine whether the
STAT1 and STAT2 transcription factors were present in one or more of
these bands, nuclear extracts were incubated with either anti-STAT1
or anti-STAT2 antibody prior to addition of the probe. With the Oas1a
probe, the upper bandwas not detectedwhen STAT1 antibodywas pre-
sent, and a supershift band (indicated by an arrow)was observedwhen
STAT2 antibody was present. With the Oas1b probe, a decrease in the
intensity of the upper band was observed when STAT1 antibody was
added and a supershift band was detected when the STAT2 antibody
was added. The addition of a nonspeciﬁc rabbit IgG did not alter the
band patterns of either probe. The results suggested that both STAT1
and STAT2 were present in the upper complex band detected by both
probes. In order to conﬁrm the validity of the supershift data, theFig. 3. Functional analysis of the predicted Oas1a and Oas1b ICEs. (A) Luciferase reporter ass
(−854, +28) and Oas1b (−576, +51) constructs were substituted as indicated in Fig. 2. A
treated with murine IFN beta (1000 U/ml) for 3 h or untreated and then luciferase activit
Renilla luciferase activity. Error bars represent SEM (n=3). Statistical signiﬁcance was det
and Oas1a DNA probes containing either a wild type or mutated ICE and nuclear extracts f
speciﬁc competitor DNA was added prior to addition of the probe in the indicated reacti
probe was detected using anti-DIG antibody. The results shown are representative of at leabinding of STAT1 and STAT2 to the ISREs in the Oas1a and Oas1b pro-
moters in cells stimulated with IFN beta was analyzed by ChIP (Figs. 4B
and C). Pilot ChIP experiments showed that the levels of STAT1 and
STAT2 bound to these ISG promoters was higher at 30 m than at 3 h
after treatmentwith IFNbeta. C3H/He cellswere left untreated or treated
with 1000 U/ml of IFN beta for 30 m and then treated with formalde-
hyde. Crosslinked DNA–protein complexes were immunoprecipitated
using anti-STAT1, anti-STAT2 or a nonspeciﬁc IgG antibody. The cross-
links were reversed and the immunoprecipitated DNA was puriﬁed
and quantiﬁed by real time qPCR. The results showed that both STAT1
and STAT2 are present on the Oas1a and Oas1b promoters after stimula-
tion of C3H/He cells by IFN beta. Although one of the two anti-IRF-9 an-
tibodies (Santa Cruz Biotechnology) tested detected IRF-9 in Western
blots, neither of these antibodies was found to be suitable for EMSA
nor ChIP. Therefore, the interaction of IRF-9 with the ISREs of these pro-
moters could not be directly tested.
Functional analysis of TFBSs predicted in the Oas1a and Oas1b promoters
The GENOMATIX search done in the present study predicted a
STAT site overlapping the 5′ end and an IRF site overlapping the 3′
end of both the Oas1a and Oas1b ISREs (Fig. 2). These predictions sug-
gested that the sequences located immediately upstream and down-
stream of the ISRE might be important for stabilizing the binding of
STAT1 and IRF-9 to the core ISRE and/or for facilitating the binding
of additional STAT and IRF factors. To functionally test these predic-
tions, the ISRE and overlapping STAT and IRF TFBSs were individuallyays were done with control and mutated ICE constructs. Two nts in the ICE of the Oas1a
t 24 h after transfection of a wild type or mutant construct, C3H/RV MEFs were either
ies were analyzed. Fireﬂy luciferase activity measured in triplicate was normalized to
ermined with a Student's t test (*, Pb0.05; **, Pb0.005). (B) EMSA. DIG-labeled Oas1b
rom C3H/RV MEFs were used for the binding reactions. A 200 fold excess of unlabeled
ons. DNA–protein complexes were resolved on 6% native gels and the bound labeled
st two independent experiments.
Fig. 4. Binding of STAT1 and STAT2 to the Oas1a and Oas1b promoters in vitro and in vivo. (A) DIG-labeled Oas1b and Oas1a DNA probes and nuclear extracts from untreated or
murine IFN beta (1000 U/ml) treated C3H/RV MEFs were used for EMSA. Anti-STAT1, anti-STAT2 or a nonspeciﬁc IgG antibody was added to the nuclear extract prior to addition
of the probe. DNA–protein complexes were resolved on 6% native gels and the labeled probe was detected with anti-DIG antibody. The results shown are representative of at least
two independent experiments. ChIP analysis of the binding of STAT1 or STAT2 to the (B) Oas1a or (C) Oas1b promoter in control or 30 min IFN beta treated C3H/He cells. The
amounts of precipitated Oas1a and Oas1b promoter DNA were quantiﬁed by real-time qPCR using promoter-speciﬁc primers and ﬂuorogenic TaqMan FAM/MGB probes. Nonspe-
ciﬁc IgG antibody was used as a negative control and averaged values are shown. The bars represent standard deviation (SD) (n=3).
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structs as indicated in Fig. 2. The luciferase activity of each mutated
reporter construct after stimulation with murine IFN beta was com-
pared to that of the wild type construct. A GENOMATIX search con-
ﬁrmed that the introduced mutations eliminated the targeted
binding site but did not create a new TFBS. Mutation of the ISRE (3′
GAAA to 3′ GTAC) in the Oas1a (Fig. 5A) and Oas1b (Fig. 5B) con-
structs reduced the basal activities of both promoters by more than
80% suggesting that the ISRE plays a role in modulating the basal ex-
pression of Oas1a and Oas1b. Low levels of IFN were previouslyFig. 5. Effect ofmutation of the ISRE or overlapping/adjacent TFBSs on Oas1a and Oas1b promot
luciferase activities of control and mutated (A) Oas1a and (B) Oas1b reporter constructs were a
were treated with 1000 U/ml of murine IFN beta for 3 h or left untreated. Fireﬂy luciferase ac
shown are the average of three independent experiments. Error bars represent SEM (n=3). Sreported to be secreted by unstimulated, cultured MEFs (Takaoka
and Yanai, 2006) and this could explain the negative effect of the
ISRE mutation on basal expression. No increase in activity above
basal levels was observed for either the Oas1a or Oas1b promoter
with a mutated ISRE after stimulation with IFN beta conﬁrming that
the ISRE is required for IFN beta-induction of both genes.
The predicted IRF site overlapping the 3′ end of the ISRE was mu-
tated at the −5 and −7 positions in the Oas1a promoter and at the
−6 and−8 positions in the Oas1b promoter (Fig. 2). Although muta-
tion of the IRF site resulted in about a 50% reduction in basal Oas1aer activity. Individual TFBSs weremutated in reporter constructs as indicated in Fig. 2. The
ssayed. Each construct was transfected into C3H/RV cells and 24 h after transfection, cells
tivity was measured in triplicate and normalized to Renilla luciferase activity. The values
tatistical signiﬁcance was determined with a Student's t test (*, Pb0.05; **, Pb0.005).
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ly upregulated by IFN (Fig. 5). IFN beta induced the wild type Oas1a
construct activity by 1.7 fold and that of the Oas1a IRF mutant con-
struct by 2.1 fold. Both the wild type and mutant IRF Oas1b constructs
showed a 1.3 fold induction after IFN treatment. These results indi-
cate that the IRF binding site overlapping the ISRE in both promoters
positively regulates basal promoter activity, but does not contribute
to the induction of these promoters by IFN beta.
Mutationswere next introduced into the STAT site overlapping the5′
end of the Oas1a and Oas1b ISREs. Substitutions were introduced at po-
sitions −20, −25 and −27 in the Oas1a promoter and at positions
−21, −26 and −28 in the Oas1b promoter (Fig. 2). Similar to what
was observed for the Oas1a construct with a mutated ISRE, the Oas1a
mutant STAT construct showed a more than an 80% reduction in basal
activity but was not upregulated by IFN beta. In contrast, mutation of
the STAT site in the Oas1b promoter only minimally affected basal or
IFN beta-induced activities. These results suggest that the STAT site
overlapping theOas1a ISRE is required for the induction of this promoter
by IFN beta, while the STAT site overlapping the Oas1b ISRE is not.
The TFBS searches done by Mashimo et al. (2003) and those done in
the present study predicted anNF-kappa B site immediately downstream
of the Oas1b ISRE but not of the Oas1a ISRE. The sequence of this site dif-
fers from theNF-kappa B consensus GGGA/GNNC/TC/TCC (Grilli et al., 1993)
at the two underlined positions (Fig. 2). Type 1 IFN binding to the IFN
alpha/beta receptor has been reported to also activate the phosphatidyli-
nositol 3 kinase (PI3K) pathway (Kaur et al., 2005) which was shown to
play a role in activating NF-kappa B (Chang et al., 2006). The Oas1b
NF-kappa B site wasmutated as indicated in Fig. 2. The luciferase activity
observed for thismutant constructwas the same as that for thewild type
constructwith andwithout IFN treatment (Fig. 5B). These results indicate
that the NF-kappa B site does not affect basal activity or modulate the
induction of the Oas1b promoter by IFN beta.
IFN beta-induction of the Oas1a and Oas1b genes in the absence of STAT1
or STAT2
As one means of determining whether STAT1 is required for the ac-
tivation of the Oas1a and Oas1b genes by IFN beta, the expression ofFig. 6. Analysis of the induction of Oas1a and Oas1b by IFN beta in wild type, STAT1−/− and
untreated. Total RNA was collected and fold induction of Oas1a and Oas1b mRNA expression l
to the level of GAPDH mRNA in the same sample. The fold change over the amount of mRNA
representative data from one of three independent experiments are shown. ND—not detected.
control 129, STAT1−/− and STAT2−/−MEFsmock treated or treatedwith 1000 U/ml of IFN be
by real-time qPCR using promoter speciﬁc primers andﬂuorogenic TaqMan FAM/MGB probes. N
bars represent SD (n=3).these genes was analyzed by real time qRT-PCR in wild type, STAT1−/
− and STAT2−/−MEFs. In wild type MEFs, Oas1a and Oas1b gene ex-
pression was efﬁciently induced by IFN beta (Fig. 6A). Basal levels of
Oas1a mRNA were not detectable in either untreated STAT1−/− or
STAT2−/−MEFs andminimal upregulation of Oas1a expression was ob-
served after incubation of these cells with IFN beta. Basal levels of Oas1b
were detected in both STAT1−/− and STAT2−/− MEFs. Although IFN
beta did not upregulateOas1b expression in STAT2−/−MEFs, it efﬁcient-
ly upregulated Oas1b expression in STAT1−/− MEFs. To conﬁrm these
observations, the binding of STAT1 and STAT2 to the Oas1a and Oas1b
promoters in control, STAT−/− and STAT2−/− MEFs was analyzed by
ChIP. Both STAT1 and STAT2 bound the Oas1a and Oas1b promoters in
IFN beta-treated control 129 MEFs but neither bound to either promoter
in the STAT2−/− MEFs (Figs. 6B and C). In contrast, STAT2 bound to
the Oas1b promoter but not to the Oas1a promoter in STAT1−/−MEFs
conﬁrming that Oas1a promoter induction by IFN beta occurs in a
STAT1- and STAT2-dependent manner, while the induction of Oas1b by
IFN beta is STAT2-dependent but can be STAT1-independent.
Discussion
The mouse genome contains 8 duplications of the Oas1 gene. As an
active 2–5A synthetase murine Oas1a functions as a broad spectrum
antiviral protein through its ability to activate RNase L (Kakuta et al.,
2002). Oas1b is an inactive synthetase that can function in a dominant
negative manner to suppress Oas1a synthetase activity (Elbahesh et
al., 2011). Oas1b also provides ﬂavivirus-speciﬁc antiviral activity
through an as yet uncharacterized mechanism that does not involve
the RNase L pathway (Scherbik et al., 2006). Based on TFBS differences
identiﬁed in theOas1a and Oas1b promoters, a previous study predicted
that these two genes may be differentially activated by IFN and/or virus
infection but this hypothesis was not functionally tested (Mashimo et
al., 2003). In the present study, a ﬁreﬂy luciferase reporter assay and
truncated and mutated promoter constructs were used to map the
Oas1a and Oas1b promoter regions required for basal activity and IFN
beta induction. For both genes, the lowest basal promoter activity was
observed with the longest promoter fragment tested but activity in-
creased signiﬁcantly with 5′ truncation suggesting the presence ofSTAT2−/− MEFs. MEFs were treated with 1000 U/ml of murine IFN beta for 3 h or left
evels was measured by real-time qRT-PCR. The mRNA level of each gene was normalized
in mock samples is expressed in RQU. Each experiment was performed in triplicate and
ChIP analysis of the binding of STAT1 or STAT2 to the (B) Oas1a or (C) Oas1b promoter in
ta for 30 min. The amounts of precipitated Oas1a andOas1b promoter DNAwere quantiﬁed
onspeciﬁc IgG antibodywas used as a negative control and averaged values are shown. The
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tion of the 5′ upstream region was previously reported to be a prerequi-
site for mapping the activation sites in the proximal promoters of the
interleukin 19 and fucosyltransferase VI genes (Chen et al., 2006; Higai
et al., 2008). Upstream sites that repress the transcriptional activation
by TFs binding to TFBSs in the proximal promoter region were also pre-
viously identiﬁed in the promoters of genes for which transcription is
known to be tightly regulated (Garban and Bonavida, 2001; Lindas and
Tomkinson, 2007). Since activation of the RNase L pathway by 2–5A
leads to degradation of not only viral but also cellular ssRNAs, it would
be expected that the expression of the Oas1 genes would be tightly
regulated.
The core promoters of the Oas1a and Oas1b genes contain an INR el-
ement and an inverted ICE. Mutation of the ICE element reduced the
basal activities of the Oas1a and Oas1b promoters by about 40% but
did not affect the induction of either promoter by IFN beta suggesting
that ICE plays a role in basal promoter activity but not in IFN-mediated
induction. The EMSA results showed that TFs in control cell nuclear ex-
tracts bound to a probewith awild type but not amutated ICE sequence.
Although the identity of the TF(s) was not determined, NF-Y, also
termed CBF (CCAAT binding factor), was previously shown to be the pri-
mary TF binding to the CCAAT element in either orientation (Mantovani,
1999). NF-Y is a ubiquitous transcription factor composed of three sub-
units that can increase the DNA binding afﬁnity of factors bound to
neighboring TFBSs (Jackson et al., 1998; Reith et al., 1994; Wright et
al., 1995) and interact with p300/CBP, GCN5 and P)CAF complexes
that mediate promoter acetylation (Currie, 1998; Jin and Scotto, 1998;
Li et al., 1998; Salsi et al., 2003). NF-Y has also been reported to recruit
RNA polymerase II to a promoter (Kabe et al., 2005). Themutation iden-
tiﬁed in the ICE of the C3H/He Oas1a promoter suggests that the basal
levels of Oas1a expression would be reduced in the cells of these mice.
Deletion analysis of the Oas1b promoter showed that the regulation
of this gene is more complex than that of the Oas1a gene. The mapping
data indicated that the region of the Oas1b promoter between −576
and −116 contains elements that enhance basal Oas1b expression.
TFBSs predicted by TFSEARCH and GENOMATIX in this region of the
Oas1b promoter that were not found in the Oas1a promoter include
C/EBPb, GATA-1, AML-1, CdxA, HSF2, IK-2, Lyf-1, and MZF-1. C/EBPb
(also known as CCAAT/enhancer-binding protein beta) was previously
shown to positively regulate gene induction by recruiting transcription-
al coactivators as well as basal transcription factors (Kowenz-Leutz and
Leutz, 1999).
Upon type I IFN stimulation, the transcription factor complex ISGF3,
composed of STAT1, STAT2 and IRF-9, binds to ISREs in ISG promoters
with the consensus sequence 5′ A/GNGAAANNGAAACT 3′ (Darnell et
al., 1994). The Oas1a and Oas1b promoters were each predicted to
have a single canonical ISRE by a previous TFSEARCH (Mashimo et al.,
2003) and also by both the GENOMATIX and TFSEARCH database
searches done in the present study. Since the structure of ISGF3/DNA
complexhas not yet been solved is not clear exactly how the ISGF3 com-
plex components bind to the ISRE. It was previously reported that
STAT1 recognizes the 5′ GAAA sequence and IRF-9 recognizes the 3′
GAAA sequence in the ISRE. STAT2 does not stably bind to DNA but in-
teractswith both STAT1 and IRF-9 and is essential for the transcriptional
activity of the ISGF3 complex (Bluyssen et al., 1995; Qureshi et al.,
1995). The substitutions introduced into the ISRE 3′ GAAA in both the
Oas1a and Oas1b promoters abolished IFN beta induction indicating
that this region is required for IFN beta induction of these ISGs. A GAS
site was previously predicted to overlap the 5′ end of the Oas1b ISRE
but not that of the Oas1a (Mashimo et al., 2003). GAS elements were
originally identiﬁed in the promoters of IFN-gamma responsive genes.
Upon IFN-gamma stimulation, a STAT1 homodimer, also referred to as
the gamma interferon activation factor (GAF), was shown to bind to
GAS elements with the consensus sequence TTCN2–4GAA (Decker et
al., 1997). Although other STATs can bind to this consensus sequence,
the DNA binding speciﬁcities of different STAT proteins depends onthe length of the spacer sequence and speciﬁc nts in both the binding
site and immediately adjacent to it (Darnell, 1997; Decker et al., 1997;
Ehret et al., 2001). The GENOMATIX search done in this study predicted
a STAT binding site overlapping the 5′GAAAmotif of the ISRE in both the
Oas1a and Oas1b promoters. Substitution of the G in this ISREmotif was
reported to prevent the binding of STAT1 but not of the IRF-9/STAT2
complex (Bluyssen and Levy, 1997). Mutation of the Oas1a STAT site in-
cluding the G mentioned above abolished IFN beta-induced promoter
activity suggesting that the binding of STAT1 is crucial for the induction
of this promoter by IFN beta. In contrast,mutation of the saments in the
Oas1b STAT site did not signiﬁcantly reduce upregulation by IFN beta.
Consistent with these observations, the Oas1b gene but not the Oas1a
gene was efﬁciently upregulated in IFN-treated STAT1−/− MEFs con-
ﬁrming that the induction of Oas1b by IFN beta does not require STAT1.
Although the sequences of the Oas1a and Oas1b ISREs are identical,
the STAT sites overlapping the 5′ ISRE GAAA motif differ by one nt,
Oas1a (TTCTCGGGAA) and Oas1b (TTCCCGGGAA). A previous report
proposed that the presence of an A, G or T at this position promotes
STAT2 binding (Tenoever et al., 2007). However, the ﬁnding in the pre-
sent study that IFNbeta activation of theOas1a promoterwith a T in this
position is STAT1-dependent while activation of the Oas1b promoter
with a C in this position is STAT1-independent suggests that this site
is important for stabilizing STAT1 binding and that the substitution at
this site is responsible for the differential STAT1 dependence between
these two promoters. Although other ISGs, such as Adar1, APOBEC3G
and Irf7, were previously reported to be upregulated by type I IFN in a
STAT1-independent manner, the TF complexes involved in the STAT1-
independent activation of ISGs by type I IFN have not yet been well
characterized (George et al., 2008; Ousman et al., 2005; Sarkis et al.,
2006). Expression of an IRF-9/STAT2 fusion protein efﬁciently activated
the transcription of an ISRE-dependent luciferase reporter in the ab-
sence of type I IFN stimulation (Kraus et al., 2003). Also, an IRF-9/
STAT2 complex was sufﬁcient to induce the expression of a reporter
construct containing the RIG-G gene promoter upon stimulation with
IFN alpha (Lou et al., 2009). However, it is currently not knownwhether
additional factors are also involved in STAT1-independent upregulation
of ISGs by type I IFN.
The GENOMATIX search predicted an IRF binding site overlapping
the 3′GAAA motif of the ISRE in both the Oas1a and Oas1b promoters
and an NF-kappa B binding site immediately downstream of the Oas1b
ISRE. Although these sites were not found to be involved in gene activa-
tion by IFN, they may be involved in the upregulation of these genes in
virus-infected cells. It was previously reported that IRF-3, IRF-7 and
NF-kappa B transcription factors are activated during viral infections
and mediate induction of type I IFN as well as upregulate a subset of
ISGs independently of IFN (Andersen et al., 2008; Barnes et al., 2004;
Basagoudanavar et al., 2011; Elco et al., 2005; Grandvaux et al., 2002;
Nakaya et al., 2001; Peters et al., 2002).
Low levels of IFN produced by uninfected cells are required for
maintaining basal levels of ISGs (Taniguchi and Takaoka, 2001). Low
level constitutive expression of ISGs in uninfected cells is thought to
be crucial for mounting an effective antiviral response in the initial
stages of a virus infection (Basagoudanavar et al., 2011). However,
the data obtained in this study indicated that basal expression of nei-
ther Oas1a nor Oas1b is solely dependent on type I IFN. Many viruses
antagonize type I IFN signaling and the induction of antiviral ISGs by
blocking the activation of the Jak-STAT signaling pathway (Diamond,
2009; Randall and Goodbourn, 2008). The observations made in this
and other studies that Oas1b and some other ISGs can be induced
by type I IFN in a STAT1-independent manner indicate that an effec-
tive antiviral response can still be mounted in infected cells when
STAT1 activation/translocation is blocked. The importance of an alter-
native STAT1-independent response in providing host protection was
reported for dengue virus (another ﬂavivirus) in a mouse model
(Perry et al., 2011). However, other types of viruses, such as measles
virus and lymphocytic choriomeningitis virus, have been reported to
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expansion through a STAT2-dependent but STAT-1-independent
pathway (Hahm et al., 2005).
Materials and methods
Cells
SV40-T antigen transformed C3H/He and C3H/RV MEFs were grown
in minimal essential medium (MEM) supplemented with 5% fetal bo-
vine serum (FBS) and 10 μg/ml gentamicin. Transformed 129/SvEv,
STAT1−/− and STAT2−/−MEF lines (provided by Christian Schindler,
Columbia University, NewYork, NY)were grown inMEMsupplemented
with 10% FBS and 1% PenStrep (Gibco).
Quantiﬁcation of mRNA levels
Real time quantitative reverse transcription-PCR (qRT-PCR) ana-
lyses of mouse Oas1a and Oas1b gene expression were performed
using a 50 μl reaction mixture containing 500 ng of total cellular
RNA, the primer pair (1 μM), and the probe (0.2 μM) in an Applied
Biosystems 7500 Sequence Detection System. Applied Biosystems
Assays-on-Demand 20× primer and ﬂuorogenic TaqMan FAM/MGB
probe mixes (Mn00836412_m1 for Oas1a and Mn00449297_m1 for
Oas1b) were used. Glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) mRNA was used as an endogenous control for each sample
and was detected using TaqMan mouse GAPDH primers and probe
(Applied Biosystems). One-step RT-PCR was performed for each target
gene and for the endogenous control in a singleplex format using
200 ng of RNA and the TaqMan One-Step RT-PCR Master Mix Reagent
Kit (Applied Biosystems). The cycling parameters were as follows: re-
verse transcription at 48 °C for 30 m, AmpliTaq activation at 95 °C for
10 m, denaturation at 95 °C for 15 s, and annealing/extension at
60 °C for 1 m (cycle repeated 40 times). The values were normalized
to those for GAPDH and presented as the relative fold change com-
pared to the uninfected calibrator sample in relative quantiﬁcation
(RQ) units as previously described (Scherbik et al., 2007).
Cloning the Oas1a and Oas1b gene promoter regions
A DNA fragment consisting of 1768 bp upstream and 28 bp down-
stream of the Oas1a gene TSS and a fragment consisting of 1398 bp up-
stream and 51 bp downstream of the Oas1b TSS were ampliﬁed from
C3H/He and C3H/RV genomic DNA using primers designed from the
GenBank C57BL/6J mouse genomic sequence [(NCBI) Genbank ID:
NT_078458.6]. The ampliﬁed PCR products were cloned into a TopoXL
vector (Invitrogen) and sequenced. The C3H/RV DNA fragments were
then subcloned into the pGL4.17 ﬁreﬂy luciferase reporter vector (Pro-
mega) using NheI and BgLII cloning sites to generate the Oas1a
(−1768, +28) and Oas1b (−1398, +51) reporter constructs. These
two constructs were subsequently used as templates in additional PCR
reactions to amplify DNA fragments containing sequential 5′ deletions.
Each of the deleted PCRproductswas then cloned into thepGL4.17ﬁreﬂy
luciferase reporter vector to generate eight additional Oas1a reporter
constructs [Oas1a (−854, +28), Oas1a (−722, +28), Oas1a (−641,
+28), Oas1a (−468, +28), Oas1a (−396, +28), Oas1a (−289, +28),
Oas1a (−176, +28) and Oas1a (−87, +28)] and eight additional
Oas1b reporter constructs [Oas1b (−991, +51), Oas1b (−814, +51),
Oas1b (−742, +51), Oas1b (−576, +51) Oas1b (−507, +51), Oas1b
(−394, +51), Oas1b (−181, +51), and Oas1b (−116, +51)]. The
primers used for these PCR reactions are listed in Table 1.
Prediction and mutation of TFBSs
The TFSEARCH (version 1.3) and GENONATIX programs were used to
predict TFBSs in the Oas1a and Oas1b promoter fragment sequences.Speciﬁc mutations in predicted IRF, ISRE, STAT and ICE binding sites
(Fig. 2) were introduced into the promoter sequence in the Oas1a
(−854, +28) construct to generate the Oas1a (−854, +28) mIRF,
Oas1a (−854, +28) mISRE, Oas1a (−854, +28) mSTAT and Oas1a
(−854, +28) mICE reporter constructs, respectively. Speciﬁc mutations
in the predicted NF-kappa B, IRF, ISRE, STAT and ICE binding sites
(Fig. 2)were introduced into theOas1b (−576,+51) construct to gener-
ate the Oas1b (−576, +51) mNF-kappa B, and Oas1b (−576, +51)
mIRF, Oas1b (−576, +51) mISRE, Oas1b (−576, +51) mSTAT Oas1b
(−576, +51) mICE constructs, respectively. The mutations were intro-
duced using the primers shown in Table 2 and a QuikChange II Site-
Directed Mutagenesis Kit (Stratagene) according to the manufacturer's
protocol. The mutant promoter sequences were analyzed using GENO-
MATIX software to ensure that the substitutions introduced eliminated
the targeted binding site but did not create a new TFBS. The sequences
of all the constructs generated were veriﬁed by DNA sequencing.
Luciferase reporter assay
The pGL4.17 ﬁreﬂy luciferase reporter plasmid DNA (1 μg) contain-
ing either anOas1a or Oas1b promoter fragment and 20 ng of a pGL4.74
Renilla luciferase reporter construct DNA (Promega) in a solution con-
sisting of 3 μl of FuGENE 6 (Roche Applied Science) and 97 μl of serum
free media were added to C3H/RV MEF cultures (50–70% conﬂuency)
and the cells were incubated at 37 °C for 24 h. Murine recombinant
IFN beta (1000 U/ml) (PBL Interferon Source) was added to the cell cul-
tures 21 h after transfection. After a 3 h incubation, cellswere harvested
using the lysis buffer supplied with the Dual Luciferase Reporter Assay
System (Promega). Fireﬂy and Renilla luciferase activities were sepa-
rately measured according to the manufacturer's protocol using a
luminometer (LMax II384, Molecular Devices). The ﬁreﬂy luciferase ac-
tivity was normalized to the Renilla luciferase activity in each sample.
Electrophoretic mobility shift assay (EMSA)
The Oas1a and Oas1b DNA probes (Table 3) were labeled using a
DIG gel shift 2nd generation kit (Roche Applied Science) according
to the manufacturer's instructions. Nuclear extracts (2 μg) prepared
from C3H/RV MEFs that were either untreated or treated with
1000 U/ml of murine IFN beta for 1 h were used for EMSA. The spec-
iﬁcity of the binding detected was analyzed by addition of a 200 fold
excess of unlabeled probe to one of the reactions. For supershift as-
says, nuclear extracts were incubated with anti-STAT1 (Santa Cruz
Biotechnology Inc.), anti-STAT2 (provided by Christian Schindler,
Colombia University, New York, NY) or a nonspeciﬁc IgG antibody
(Zymed) for 30 m at room temperature. Binding reactions were pre-
pared according to the DIG gel shift 2nd generation kit protocol.
DNA–protein complexes were resolved on a 6% native polyacrylamide
gel and labeled probe was detected using the anti-DIG antibody sup-
plied with the kit.
ChIP
Conﬂuent C3H/He monolayers were incubated with 1000 U/ml of
murine IFNbeta for 30 min or left untreated. Chromatinwas crosslinked
in situ with 1% formaldehyde for 10 min at ~25 °C. After washing with
ice cold phosphate-buffered saline (PBS), cells were incubated with
1 ml of cell lysis buffer [5 mM PIPES pH 8.0, 85 mM KCl, 0.5% NP40
and Complete EDTA-free Protease Inhibitors (Roche Applied Sciences)]
for 10 m and the nuclei were pelleted at 2000 rpm at 4 °C. Nuclei were
then incubatedwith SDS lysis buffer (1% SDS, 10 mMEDTA, 50 mMTris
pH 8.0, and Complete EDTA-free Protease Inhibitors) for 20 m on ice.
The crosslinked chromatin was sonicated to an average size of
500–1000 base pairs. Sonicated chromatin obtained from 1×106 cells
was used for each immunoprecipitation reaction. Samples were ﬁrst
precleared with 60 μl of salmon sperm DNA-coated agarose beads
Table 1
Primers used to generate the Oas1a and Oas1b promoter deletion reporter constructs.
Construct Forward primer Reverse primer
Oas1a (−854 to +28) AGCTAGCTAGGCTCGGGGACCAGTAGTAGa AAGATCTGCTAAGTCTGGAGCTTCCTGGa
Oas1a (−722 to +28) AGCTAGCGCCCATGAGTGATCCTCCA AAGATCTGCTAAGTCTGGAGCTTCCTGG
Oas1a (−641 to +28) AGCTAGCTCAACCTTGGGAATGTCCTGG AAGATCTGCTAAGTCTGGAGCTTCCTGG
Oas1a (−468to +28) AGCTAGCGATGTGAGTAAGAGAGGGGGC AAGATCTGCTAAGTCTGGAGCTTCCTGG
Oas1a (−396 to +28) AGCTAGCAAAGAAAGAAAGAAAGGAAGAAAG AAGATCTGCTAAGTCTGGAGCTTCCTGG
Oas1a (−289 to +28) AGCTAGCTGGAAGCCACAGCCACCTTCTGCAG AAGATCTGCTAAGTCTGGAGCTTCCTGG
Oas1a (−176 to +28) AGCTAGCAGAAGAAACCCCAAGAAAGCCAG AAGATCTGCTAAGTCTGGAGCTTCCTGG
Oas1a (−87 to +28) AGCTAGCTGGTCAGAAGCTCTGAAGCC AAGATCTGCTAAGTCTGGAGCTTCCTGG
Oas1b (−1398 to +51) AGCTAGCTTTTTCCCCCTCACACTCTG AAGATCTCCTCTGCAGCCAGCAGGTCCT
Oas1b (−991 to +51) AGCTAGCCCAATCCTGCTCTTGCAGAAGGC AAGATCTCCTCTGCAGCCAGCAGGTCCT
Oas1b (−814 to +51) AGCTAGCGTGTGTGTGTGTGTGTGTTTGGGAC AAGATCTCCTCTGCAGCCAGCAGGTCCT
Oas1b (−742 to +51) AGCTAGCACAGCCCGAGCTCTTAAACTCTGAG AAGATCTCCTCTGCAGCCAGCAGGTCCT
Oas1b (−507 to +51) AGCTAGCAGACCCCACCCTCACCCAGAC AAGATCTCCTCTGCAGCCAGCAGGTCCT
Oas1b (−394 to +51) AGCTAGCACCTGCAAGTCCAGAGGTAAAGG AAGATCTCCTCTGCAGCCAGCAGGTCCT
Oas1b (−181 to +51) AGCTAGCCAGAAGAAATCCCGAGAAAG AAGATCTCCTCTGCAGCCAGCAGGTCCT
Oas1b (−116 to +51) AGCTAGCGTACCTGTTCAGAAGCCCTAACGCC AAGATCTCCTCTGCAGCCAGCAGGTCCT
a Underlined sequences indicate an NheI restriction site included in all forward primers and a BglII restriction site included in the reverse primers.
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technology), anti-STAT2 (provided by Christian Schindler, Columbia
University, New York, NY) or rabbit nonspeciﬁc IgG antibody overnight
at 4 °C. After incubationwith 60 μl salmon sperm-coated agarose beads,
the samples were washed sequentially for 5 m at 4 °C with each of the
following buffers: low salt buffer (0.1% SDS, 1% Triton X-100, 2 mM
EDTA, 20 mM Tris, pH 8.0 and 150 mM NaCl), high salt buffer (0.1%
SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris, pH 8.0 and 500 mM
NaCl) and LiCl buffer (0.25 M LiCl, 1% NP40, 1% DOC, 1 mM EDTA andTable 2
Primers used for site directed mutageneis.
Construct Primer Primer sequence
Oas1a
(−854,
+28)
mIRF
Fa GCCCTTCTCGGGAAATGGAAACTGTACATCTACTTCCCb
R GGGAAGTAGATGTACAGTTTCCATTTCCCGAGAAGGGC
Oas1a
(−854,
+28)
mISRE
F GCCCTTCTCGGGAAATGGTACCTGAAAATCTACTTCCC
R GGGAAGTAGATTTTCAGGTACCATTTCCCGAGAAGGGC
Oas1a
(−854,
+28)
mSTAT
F CATAGCCCTGCCCGTGTCGGCAAATGGAAACTG
R CAGTTTCCATTTGCCGACACGGGCAGGGCTATG
Oas1a
(−854,
+28)
mICE
F CAGAAGCTCTGAAGCCATCCGCTGCCGGGGCCTGG
R CCAGGCCCCGGCAGCGGATGGCTTCAGAGCTTCTG
Oas1b
(−576,
+51)
mNF-
kappa B
F CCCGGGAAATGGAAACTGAAAGGACCATTTCTGCTTCAGCG
R CGCTGAAGCAGAAATGGTCCTTTCAGTTTCCATTTCCCGGG
Oas1b
(−576,
+51)
mIRF
F CCCGGGAAATGGAAACTGTACGTCCCATTTCTGCTTCAGCG
R CGCTGAAGCAGAAATGGGACGTACAGTTTCCATTTCCCGGG
Oas1b
(−576,
+51)
mISRE
F GCCCTTCCCGGGAAATGGTACCTGAAAGTCCC
R GGGACTTTCAGGTACCATTTCCCGGGAAGGGC
Oas1b
(−576,
+51)
mSTAT
F GCATATCCGCGCCCGTGCCGGCAAATGGAAACTGAAAGTCCC
R GGGACTTTCAGTTTCCATTTGCCGGCACGGGCGCGGATATGC
Oas1b
(−576,
+51)
mICE
F CAGAAGCCCTAACGCCATCCGCTGCTCGGGCCTGG
R CCAGGCCCGAGCAGCGGATGGCGTTAGGGCTTCTG
a F, forward primer; R, reverse primer.
b Underlined letters indicate mutated nts.10mM Tris, pH 8.0). Finally, the samples were washed twice with TE
buffer (1 mM EDTA and 10 mM Tris, pH 8.0), and then eluted with
500 μl of SDS elution buffer (1% SDS, 0.1 M NaHCO3). Samples were
incubated with 20 μl of 5 M NaCl at 65 °C overnight to reverse the
crosslinks, then 10 μl of 500 mM EDTA, 20 μl of Tris pH 6.5, and 2 μl
of Proteinase K (10 mg/ml) were added and the samples were incu-
bated for 1 h at 45 °C. Input and immunoprecipitated DNA were iso-
lated using a phenol:chloroform:isoamyl alcohol mixture (USB
Biochemicals) according to the manufacturer's protocol and analyzed
by real time quantitative PCR (qPCR) using probes and primers designed
to span the proximal Oas1a and Oas1b promoters. The sequences of the
primers were: Oas1a forward primer 5′-GGATCCTAAGAAAGCTCA-
GACTTCA-3′, Oas1a reverse primer 5′-CCCGGCAGCCAATGG-3′, Oas1b
forward primer 5′-GAAGCCCTAACGCCATTGG-3′, Oas1b reverse primer
5′-AGGGCGCGGATATGCA-3′. The sequence of the FAM-MGB Oas1a
probe was 5′-TGGAAGTGTGGGAAAGGTCTTT-3′ and that of the Oas1b
probe was 5′-CGGGCCTGGATGAT-3′. To generate standard curves,
known amounts of Oas1a, Oas1b and Irf7 promoter DNA in a TOPO-XL
vector (Invitrogen) were titrated and assayed by real time qPCR using
a FastStart Universal Probe Master (ROX) kit (Roche Applied Science)
according to the manufacturer's protocol. The standard curves were in-
dependently generated at the same time as the immunoprecipitated
DNA samples were assayed by qPCR and used to quantify the immuno-
precipitated DNA.
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